5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5849 | JMS-17-2 | CXCR | |
JMS-17-2 is a potent and selective antagonist of CX3CR1( IC50 : 0.32 nM). | |||
T14384 | AZD8797 | KAN-0440567,KAND567 | CXCR |
AZD8797 (KAND567) is an orally available, selective and potent human CX3CR1-converting antagonist with inhibitory effects on CX3CR1 and CXCR2, and potentially protects against SARS-CoV-2-induced neuronal damage, preventi... | |||
T39879 | JMS-17-2 hydrochloride | ||
JMS-17-2 hydrochloride, a highly potent and selective CX3CR1 antagonist with an IC 50 value of 0.32 nM, effectively impedes the metastatic seeding and colonization process of breast cancer cells. | |||
T11140 | E6130 | CXCR | |
E6130 may be effective in the treatment of inflammatory bowel disease and is a highly selective CX3CR1 regulator for oral administration. | |||
T41016 | Vercirnon sodium | GSK-1605786 sodium,CCX282-Bsodium,Traficet-ENsodium | |
Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent CCR9 antagonist. It effectively inhibits CCR9-mediated calcium mobilization and chemotaxis in Molt-4 cells, exhibiting IC50 values of 5.4 nM... |